
Lead Capital Partners and Petra Capital Partners Propel Lieberman’s Growth with Strategic Platform Investment
In a landmark move set to bolster its position as a leader in primary market research, Lieberman, Inc., a premier research and analytics firm, has secured a strategic investment from Lead Capital Partners, LLC (LCP) and Petra Capital Partners. This transaction marks the second platform investment from LCP Fund II and underscores the growing demand for data-driven insights in the pharmaceutical, healthcare, and consumer industries. The partnership aligns Lieberman’s decades of expertise with the financial backing and operational support of two seasoned private equity firms, positioning the company for accelerated growth while maintaining its commitment to delivering exceptional client service.
A Legacy of Excellence: Lieberman’s Impact on Market Research
Founded in 1981, Lieberman has carved out a reputation as an innovative and trusted provider of custom market research solutions. With a focus on both quantitative and qualitative methodologies, the company engages directly with physicians, patients, and consumers to deliver tailored insights that drive decision-making for its clients. Leveraging proprietary tools and advanced analytics, Lieberman specializes in areas such as:
- Attitude and Usage Tracking: Understanding how consumers interact with brands over time.
- Brand Health and Positioning: Providing actionable strategies to enhance brand perception and market presence.
- Competitive Intelligence: Offering deep dives into competitor strategies and market dynamics.
- Patient Journey Mapping: Uncovering critical touchpoints in healthcare delivery to improve patient outcomes.
- Product and Pricing Strategy: Helping companies optimize their offerings for maximum impact.
- Market Segmentation: Identifying target audiences and tailoring campaigns to meet their unique needs.
The company’s ability to combine cutting-edge technology with nuanced qualitative research has earned it long-standing relationships with blue-chip clients across diverse industries. In 2016, Lieberman further expanded its capabilities by acquiring FRC Research, a dedicated consumer division that strengthened its foothold in non-healthcare sectors. Today, Lieberman operates as a global leader in market research, empowering organizations to make informed decisions in product development, marketing, and beyond.
A Transformative Partnership: Aligning Vision and Values
The collaboration between Lieberman, Lead Capital Partners, and Petra Capital Partners represents more than just a financial transaction—it’s a shared vision for growth and innovation. According to Karl LiVigni, Partner at Lieberman, “Partnering with LCP represents a transformative opportunity for Lieberman. We’ve found in LCP a partner deeply aligned with our culture and values, and their proven expertise in building enduring partnerships will enable us to scale while maintaining our commitment to delivering exceptional services to our clients.”
For Pryor Smartt, Managing Partner at Lead Capital Partners, the investment reflects confidence in Lieberman’s leadership and market potential. “We are thrilled to collaborate with Lieberman as it continues to strengthen its leadership in primary market research,” said Smartt. “Lieberman’s reputation for delivering insightful, data-driven solutions empowers organizations to make well-informed decisions in product development and marketing. We are excited to support the Company’s growth and ongoing success in the years ahead.”
This alignment of goals ensures that Lieberman will continue to operate under the guidance of its existing management team, preserving the company’s culture and client-centric approach while leveraging the resources and expertise of its new partners.
Why Lieberman? The Appeal of Data-Driven Insights
In today’s fast-paced business environment, companies rely heavily on accurate, actionable insights to navigate complex markets. Lieberman’s ability to deliver these insights—backed by four decades of experience—makes it a valuable asset in the eyes of investors like Lead Capital Partners and Petra Capital Partners.
The pharmaceutical and healthcare industries, in particular, face mounting pressure to innovate while addressing regulatory challenges and shifting consumer demands. By partnering with Lieberman, these sectors gain access to unparalleled expertise in understanding patient behaviors, tracking market trends, and mapping competitive landscapes. Similarly, Lieberman’s consumer division provides brands with the tools they need to stay ahead in an increasingly competitive marketplace.
About Lead Capital Partners: Driving Growth in Healthcare Services
Based in Nashville, Tennessee, Lead Capital Partners is a private equity firm with a laser focus on the lower middle market within the healthcare services sector. With over 40 years of combined investing experience, LCP’s principals specialize in partnering with founders and entrepreneurs to unlock the full potential of small businesses. Their approach combines capital resources, operational expertise, and an extensive industry network to build enduring value.
By choosing Lieberman as its second platform investment from LCP Fund II, Lead Capital Partners reaffirms its commitment to supporting innovative companies poised for growth. For more information about Lead Capital Partners, visit www.leadcp.com.

About Petra Capital Partners: Fueling High-Growth Companies
With a storied history spanning over 25 years, Petra Capital Partners has established itself as a trusted partner for high-growth companies across the United States. The firm’s investment team has deployed more than $900 million in capital into over 100 businesses, focusing primarily on sectors such as business services, tech-enabled services, and healthcare services.
Through its current SBIC fund, Petra Growth Fund V, the firm can invest up to $25 million per company in either equity or debt securities. This flexibility allows Petra to tailor its investments to the unique needs of each portfolio company, ensuring sustainable growth and long-term success. For more details, visit www.petracapital.com.
What’s Next for Lieberman?
With the backing of Lead Capital Partners and Petra Capital Partners, Lieberman is well-positioned to expand its reach and capabilities. The infusion of capital will enable the company to invest in new technologies, enhance its service offerings, and explore opportunities for geographic expansion. At the same time, the partnership ensures that Lieberman remains true to its core mission: delivering actionable insights that empower clients to achieve their goals.
As industries continue to evolve, the demand for reliable market research will only grow stronger. By combining Lieberman’s expertise with the strategic support of its new partners, this collaboration promises to shape the future of data-driven decision-making in healthcare, pharmaceuticals, and beyond.
For more information about Lieberman and its services, please visit www.liebermanresearch.com.